XmAb 5592 is a humanized, Fc-engineered antibody targeting HM1.24 with improved affinity for both FcgammaRIIIa and FcgammaRIIa receptors, enhancing lysis of HM1.24-specific multiple myeloma (MM) cells through both antibody-dependent cellular cytotoxicity (ADCC)
CAS Nummer:
[1221901-33-2]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten